Skip to main content

and
  1. No Access

    Article

    WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. β-Catenin (CTNNB1)-mutated HCC represents 30% of cases of the disease with no precision therapeutics available. Using chemical...

    Alex Rialdi, Mary Duffy, Alex P. Scopton, Frank Fonseca, Julia Nanyi Zhao in Nature Cancer (2023)